Acromegaly is a rare hormonal disorder, but awareness and diagnosis rates are improving. The growth of the Acromegaly Market reflects ongoing advancements in rare disease management.

The condition is caused by excessive growth hormone production, usually due to a pituitary tumor. Early detection is essential to prevent complications such as cardiovascular disease and diabetes.

Treatment options include surgery, radiation therapy, and hormone-suppressing medications. Long-acting injectable therapies are enhancing patient compliance and improving long-term outcomes.

With stronger research funding and better screening programs, patients now have improved access to targeted therapies.

❓ Frequently Asked Questions

Q1: What causes acromegaly?
It is caused by excess growth hormone production, often from a pituitary tumor.

Q2: Is acromegaly treatable?
Yes, with surgery, medications, and sometimes radiation therapy.